Transfer of Veno-venous Extracorporeal Membrane Oxygenation Patients With COVID-19 Associated Acute Respiratory Distress Syndrome.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 08 2023
01 08 2023
Historique:
medline:
3
8
2023
pubmed:
6
5
2023
entrez:
5
5
2023
Statut:
ppublish
Résumé
Interhospital transport of acute respiratory distress syndrome (ARDS) patients bears transport-associated risks. It is unknown how interhospital extracorporeal membrane oxygenation (ECMO) transfer of COVID-19 patients by mobile ECMO units affects ARDS mortality. We compared the outcome of 94 COVID-19 patients cannulated in primary care hospitals and retrieved by mobile ECMO-teams to that of 84 patients cannulated at five German ECMO centers. Patients were recruited from March 2020 to November 2021. Twenty-six transports were airborne, 68 were land-based. Age, sex, body-mass-index, Simplified Acute Physiology Score (SAPS) II, days invasively ventilated, and P/F-Ratio before ECMO initiation were similar in both groups. Counting only regional transports (≤250 km), mean transport distance was 139.5 km ± 17.7 km for helicopter (duration 52.5 ± 10.6 minutes) and 69.8 km ± 44.1 km for ambulance or mobile intensive care unit (duration 57.6 ± 29.4 minutes). Overall time of vvECMO support (20.4 ± 15.2 ECMO days for transported patients vs. 21.0 ± 20.5 for control, p = 0.83) and days invasively ventilated (27.9 ± 18.1 days vs. 32.6 ± 25.1 days, p = 0.16) were similar. Overall mortality did not differ between transported patients and controls (57/94 [61%] vs. 51/83 [61%], p = 0.43). COVID-19 patients cannulated and retrieved by mobile ECMO-teams have no excess risk compared with patients receiving vvECMO at experienced ECMO centers. Patients with COVID-19-associated ARDS, limited comorbidities, and no contraindication for ECMO should be referred early to local ECMO centers.
Identifiants
pubmed: 37146598
doi: 10.1097/MAT.0000000000001954
pii: 00002480-202308000-00010
pmc: PMC10627394
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
789-794Informations de copyright
Copyright © ASAIO 2023.
Déclaration de conflit d'intérêts
Disclosure: The authors have no conflicts of interest to report.
Références
J Intensive Care Soc. 2020 May;21(2):134-139
pubmed: 32489409
Lancet. 2021 May 01;397(10285):1637-1645
pubmed: 33933206
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
Am J Respir Crit Care Med. 2022 Jun 1;205(11):1354-1357
pubmed: 35212255
JAMA. 2020 Apr 7;323(13):1245-1246
pubmed: 32074258
Front Pediatr. 2016 Jun 13;4:63
pubmed: 27379221
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
J Cardiothorac Vasc Anesth. 2022 Feb;36(2):529-533
pubmed: 34088553
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Lancet Respir Med. 2020 Nov;8(11):1121-1131
pubmed: 32798468
Viruses. 2022 Jan 01;14(1):
pubmed: 35062280
ASAIO J. 2021 May 1;67(5):485-495
pubmed: 33657573
J Crit Care. 2020 Aug;58:27-28
pubmed: 32279018
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
PLoS One. 2021 Dec 7;16(12):e0260324
pubmed: 34874960
J Cardiothorac Vasc Anesth. 2021 Oct;35(10):2869-2874
pubmed: 34176676
Am J Respir Crit Care Med. 2021 Oct 15;204(8):994-997
pubmed: 34375170
ASAIO J. 2022 Feb 1;68(2):163-167
pubmed: 34802012
J Artif Organs. 2019 Mar;22(1):53-60
pubmed: 30121790
JAMA. 2020 Oct 6;324(13):1307-1316
pubmed: 32876695
Perfusion. 2023 Sep;38(6):1107-1122
pubmed: 35608047
Artif Organs. 2021 Oct;45(10):1168-1172
pubmed: 34181752
Med Intensiva (Engl Ed). 2021 Dec;45(9):e65-e67
pubmed: 34839888
Lancet. 2020 Oct 10;396(10257):1071-1078
pubmed: 32987008
Crit Care. 2021 Jun 14;25(1):211
pubmed: 34127027
ASAIO J. 2022 Apr 1;68(4):447-455
pubmed: 35184084